Pre-Emptive Immunotherapy With Purified Natural Killer Cells After Haploidentical SCT: A Prospective Phase II Study in Two Centers

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2012.162
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Targeting Natural Killer Cells for Tumor Immunotherapy

Frontiers in Immunology
AllergyImmunology
2020English

Results of Phase Ii Study of Combined Immunotherapy With Rituximab Plus Lymphokine-Activated Killer Cells as Maintenance in Follicular Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Prospective Study on the Impact of Pre-Emptive Granulocyte Infusion (PGI) in Carbapenem-Resistant Gram Negative Bacilli (CRGNB) Colonized Patients Undergoing Haploidentical HSCT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Characterization of IFNγ-producing Natural Killer Cells Induced by Cytomegalovirus Reactivation After Haploidentical Hematopoietic Stem Cell Transplantation

Oncotarget
Oncology
2016English

Interaction Between Natural Killer Cells and Regulatory T Cells: Perspectives for Immunotherapy

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2013English

Improving Natural Killer Cell Cancer Immunotherapy

Current Opinion in Organ Transplantation
AllergyImmunologyTransplantation
2015English

Natural Killer T Cell Based Immunotherapy

Journal of Vaccines & Vaccination
2012English

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy